Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Mezolar Matrix
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Mezolar Matrix 25micrograms/hour transdermal patches
0407020A0BFABAE
|
Mezolar Matrix | Fentanyl | Central Nervous System | 10,547 |
|
Mezolar Matrix 12micrograms/hour transdermal patches
0407020A0BFAAAU
|
Mezolar Matrix | Fentanyl | Central Nervous System | 9,446 |
|
Mezolar Matrix 50micrograms/hour transdermal patches
0407020A0BFACAF
|
Mezolar Matrix | Fentanyl | Central Nervous System | 6,556 |
|
Mezolar Matrix 37.5microgram/hour transdermal patches
0407020A0BFAFBW
|
Mezolar Matrix | Fentanyl | Central Nervous System | 5,450 |
|
Mezolar Matrix 75micrograms/hour transdermal patches
0407020A0BFADAG
|
Mezolar Matrix | Fentanyl | Central Nervous System | 2,671 |
|
Mezolar Matrix 100micrograms/hour transdermal patches
0407020A0BFAEAH
|
Mezolar Matrix | Fentanyl | Central Nervous System | 2,661 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.